Dna Brands Inc (DNAX) Annual Balance Sheets

Annual · GAAP · USD millions
Access DNAX quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Dna Brands Inc's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2013)
(Dec 31 2012) (Dec 31 2011)
Assets
Cash & cash equivalent0.06
Cash & Short-term Investments0.00
Accounts receivable0.01
Due from Related Parties, Current RE0.00
Inventories0.30
Prepaid Expense And Other Assets Current0.14
Total Current Assets0.51
Equipment/Property/Plant Net0.01
Other Assets, Noncurrent0.00
Total Assets0.52
Liabilities
Accounts Payable, Current AC0.41
Accrued Liabilities, Current AC1.22
Short-term Debt0.89
Other Liabilities, Current0.00
Total Current Liabilities2.85
Long-term debt0.07
Convertible Subordinated Debt, Noncurrent CO0.17
Total Long-term Debt0.24
Embedded Derivative Fair Value Of Embedded Derivative Liability0.34
Total Liabilities3.09
Stockholders' Equity
Common Stock Value0.18
Additional Paid In Capital Common Stock26.23
Retained Earnings / Accumulated Deficit-28.98
Other Equity0.00
Common Stockholder's Equity-2.57
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-2.56
Liabilities & Stockholder's Equity0.52
4 historic quarters locked

Sign in to unlock the full Dna Brands Inc balance sheet history.

About DNAX Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.